Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000049892 | SCV000795949 | pathogenic | Finnish congenital nephrotic syndrome | 2017-11-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001853055 | SCV002197172 | pathogenic | not provided | 2022-07-18 | criteria provided, single submitter | clinical testing | This premature translational stop signal has been observed in individual(s) with congenital nephrotic syndrome (PMID: 19321760). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln839Argfs*8) in the NPHS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NPHS1 are known to be pathogenic (PMID: 11317351, 11854170, 12039988). ClinVar contains an entry for this variant (Variation ID: 56479). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000049892 | SCV004191425 | pathogenic | Finnish congenital nephrotic syndrome | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Juha Muilu Group; Institute for Molecular Medicine Finland |
RCV000049892 | SCV000082301 | probable-pathogenic | Finnish congenital nephrotic syndrome | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. |